PCSA · Categories · Insider Buys
PCSA - Insider purchases
Processa Pharmaceuticals Inc. (PCSA) insider purchases - real-time wire coverage filtered to Insider Buys only.
Recent Insider Buys for PCSA
- Chief Administrative Officer Guy Wendy bought $4,701 worth of shares (2,436 units at $1.93), increasing direct ownership by 20% to 14,394 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Business - Strategy Off Lin Patrick bought $4,065 worth of shares (2,106 units at $1.93), increasing direct ownership by 19% to 13,113 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Executive Officer Ng George K bought $5,900 worth of shares (3,057 units at $1.93), increasing direct ownership by 25% to 15,492 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Financial Officer Skibsted Russell bought $6,325 worth of shares (3,277 units at $1.93), increasing direct ownership by 24% to 16,689 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Pres. Research & Development Young David bought $4,885 worth of shares (2,531 units at $1.93), increasing direct ownership by 13% to 21,729 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Pres. Research & Development Young David bought $4,589 worth of shares (2,067 units at $2.22), increasing direct ownership by 12% to 19,198 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Financial Officer Skibsted Russell bought $5,892 worth of shares (2,654 units at $2.22), increasing direct ownership by 25% to 13,412 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Executive Officer Ng George K bought $5,472 worth of shares (2,465 units at $2.22), increasing direct ownership by 25% to 12,435 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Business - Strategy Off Lin Patrick bought $4,065 worth of shares (1,831 units at $2.22), increasing direct ownership by 20% to 11,007 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (2,118 units at $2.22), increasing direct ownership by 22% to 11,958 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Pres. Research & Development Young David bought $4,590 worth of shares (1,786 units at $2.57), increasing direct ownership by 12% to 17,131 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Financial Officer Skibsted Russell bought $5,890 worth of shares (2,292 units at $2.57), increasing direct ownership by 27% to 10,758 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Executive Officer Ng George K bought $5,472 worth of shares (2,129 units at $2.57), increasing direct ownership by 27% to 9,970 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Business - Strategy Off Lin Patrick bought $4,066 worth of shares (1,582 units at $2.57), increasing direct ownership by 21% to 9,176 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Administrative Officer Guy Wendy bought $4,701 worth of shares (1,829 units at $2.57), increasing direct ownership by 23% to 9,840 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Executive Officer Ng George K bought $5,474 worth of shares (1,843 units at $2.97), increasing direct ownership by 31% to 7,841 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Pres. Research & Development Young David bought $4,589 worth of shares (1,545 units at $2.97), increasing direct ownership by 11% to 15,345 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Business - Strategy Off Lin Patrick bought $4,066 worth of shares (1,369 units at $2.97), increasing direct ownership by 22% to 7,594 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (1,583 units at $2.97), increasing direct ownership by 25% to 8,011 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Financial Officer Skibsted Russell bought $5,892 worth of shares (1,984 units at $2.97), increasing direct ownership by 31% to 8,466 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Amendment: Chief Executive Officer Ng George K bought $5,474 worth of shares (1,843 units at $2.97), increasing direct ownership by 86% to 3,979 units (SEC Form 4)4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Amendment: Chief Development Officer Bigora Sian bought $5,341 worth of shares (1,971 units at $2.71), increasing direct ownership by 36% to 7,481 units (SEC Form 4)4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Pres. Research & Development Young David bought $4,589 worth of shares (1,706 units at $2.69), increasing direct ownership by 14% to 13,813 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Financial Officer Skibsted Russell bought $5,891 worth of shares (2,190 units at $2.69), increasing direct ownership by 51% to 6,498 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Executive Officer Ng George K bought $5,471 worth of shares (2,034 units at $2.69), increasing direct ownership by 51% to 6,013 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Business - Strategy Off Lin Patrick bought $4,065 worth of shares (1,511 units at $2.69), increasing direct ownership by 32% to 6,236 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (1,748 units at $2.69), increasing direct ownership by 37% to 6,441 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Development Officer Bigora Sian bought $5,342 worth of shares (1,986 units at $2.69), increasing direct ownership by 36% to 7,496 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Amendment: Chief Executive Officer Ng George K bought $5,415 worth of shares (2,136 units at $2.54) (SEC Form 4)4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Amendment: Chief Executive Officer Ng George K bought $5,474 worth of shares (1,843 units at $2.97), increasing direct ownership by 86% to 3,979 units (SEC Form 4)4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Director Yorke Justin W bought $9,889 worth of shares (12,400 units at $0.80) (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Executive Officer Ng George K bought $69,542 worth of shares (87,200 units at $0.80) (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Pres. Research & Development Young David bought $99,289 worth of shares (124,500 units at $0.80), increasing direct ownership by 154% to 205,405 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Chief Business - Strategy Off Lin Patrick bought $34,691 worth of shares (43,500 units at $0.80) (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Young David bought $51,526 worth of shares (21,000 units at $2.45), increasing direct ownership by 36% to 79,387 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Young David bought $50,504 worth of shares (20,000 units at $2.53) (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Lin Patrick bought $9,525 worth of shares (4,000 units at $2.38), increasing direct ownership by 17% to 27,478 units (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Ng George K bought $27,000 worth of shares (10,000 units at $2.70) (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
- Yorke Justin W bought $21,544 worth of shares (8,000 units at $2.69) (SEC Form 4)4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)